Literature DB >> 29933313

Trichoblastic Carcinosarcoma of the Skin: A Case Report and Literature Review.

Ilona Okhremchuk, Anh Tuan Nguyen, Bernard Fouet, Jean-Jacques Morand1.   

Abstract

An 83-year-old man presented to the dermatology department for an ulcerated skin lesion of the back that had been increasing in size during the past 11 years. The physical examination revealed a well-defined, fleshy, reddish plaque measuring 10 × 20 cm in diameter with erosions and black areas on the surface. The patient underwent surgical excision with margins of 10 mm followed by a skin graft. Histologic section showed a lesion composed of 2 intimately intermingled epithelial and mesenchymal components associated with a basal cell carcinoma (BCC). Immunohistochemical examination showed epithelial cells that were positive for CK AE1/AE3 and p53, whereas stromal cells were positive for vimentin, CD10, and p53. BCC was positive for CD10. On the basis of these findings, a diagnosis of trichoblastic carcinosarcoma associated with BCC was made. Given the scarcity of data available in the literature regarding this diagnosis, no standard of care exists. No adjuvant treatment was provided and after 1 year of follow-up, the patient did not experience recurrence.

Entities:  

Mesh:

Year:  2018        PMID: 29933313     DOI: 10.1097/DAD.0000000000001213

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  2 in total

Review 1.  Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Follicular Differentiation.

Authors:  Iga Płachta; Marcin Kleibert; Anna M Czarnecka; Mateusz Spałek; Anna Szumera-Ciećkiewicz; Piotr Rutkowski
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

2.  Trichoblastic carcinosarcoma with panfollicular differentiation (panfollicular carcinosarcoma) and CTNNB1 (beta-catenin) mutation.

Authors:  Jenny Giang; Asok Biswas; Antien L Mooyaart; Floris H Groenendijk; Petra Dikrama; Jeffrey Damman
Journal:  J Cutan Pathol       Date:  2020-07-20       Impact factor: 1.587

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.